An explainable molecular property prediction via multi-granularity
暂无分享,去创建一个
[1] Eyal Fisher,et al. What is Interpretability? , 2020, Philosophy & Technology.
[2] Ola Engkvist,et al. Molecular representations in AI-driven drug discovery: a review and practical guide , 2020, Journal of Cheminformatics.
[3] Jürgen Bajorath,et al. Interpretation of Compound Activity Predictions from Complex Machine Learning Models Using Local Approximations and Shapley Values. , 2020, Journal of medicinal chemistry.
[4] Igor V. Tetko,et al. Transformer-CNN: Swiss knife for QSAR modeling and interpretation , 2020, Journal of Cheminformatics.
[5] Seddik Belkoura,et al. Fostering interpretability of data mining models through data perturbation , 2019, Expert Syst. Appl..
[6] Gisbert Schneider,et al. Mind and machine in drug design , 2019, Nature Machine Intelligence.
[7] Thomas Blaschke,et al. The rise of deep learning in drug discovery. , 2018, Drug discovery today.
[8] Wojciech Samek,et al. Methods for interpreting and understanding deep neural networks , 2017, Digit. Signal Process..
[9] Qinghua Hu,et al. Granular Computing Based Machine Learning in the Era of Big Data , 2017, Inf. Sci..
[10] Zachary Chase Lipton. The mythos of model interpretability , 2016, ACM Queue.
[11] Carlos Guestrin,et al. "Why Should I Trust You?": Explaining the Predictions of Any Classifier , 2016, ArXiv.
[12] Robert P. Sheridan,et al. Deep Neural Nets as a Method for Quantitative Structure-Activity Relationships , 2015, J. Chem. Inf. Model..
[13] David M. Reif,et al. Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathway , 2014, Scientific Reports.
[14] Udo Seiffert,et al. Classification in high-dimensional spectral data: Accuracy vs. interpretability vs. model size , 2014, Neurocomputing.
[15] Alex Alves Freitas,et al. Comprehensible classification models: a position paper , 2014, SKDD.
[16] Ghazaleh Ghavami,et al. Artificial neural network modeling of antimycobacterial chemical space to introduce efficient descriptors employed for drug design , 2014 .
[17] Luis Pinheiro,et al. A Bayesian Approach to in Silico Blood-Brain Barrier Penetration Modeling , 2012, J. Chem. Inf. Model..
[18] Lorenz C. Blum,et al. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13. , 2009, Journal of the American Chemical Society.
[19] Matthias Rarey,et al. On the Art of Compiling and Using 'Drug‐Like' Chemical Fragment Spaces , 2008, ChemMedChem.
[20] Alex M. Clark,et al. 2D Structure Depiction , 2006, J. Chem. Inf. Model..
[21] John S. Delaney,et al. ESOL: Estimating Aqueous Solubility Directly from Molecular Structure , 2004, J. Chem. Inf. Model..
[22] Lotfi A. Zadeh,et al. Some reflections on soft computing, granular computing and their roles in the conception, design and utilization of information/intelligent systems , 1998, Soft Comput..
[23] Michael M. Hann,et al. RECAP-Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry , 1998, J. Chem. Inf. Comput. Sci..
[24] S. Hochreiter,et al. Long Short-Term Memory , 1997, Neural Computation.
[25] David Weininger,et al. SMILES, 3. DEPICT. Graphical depiction of chemical structures , 1990, J. Chem. Inf. Comput. Sci..
[26] David Weininger,et al. SMILES. 2. Algorithm for generation of unique SMILES notation , 1989, J. Chem. Inf. Comput. Sci..
[27] David Weininger,et al. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..
[28] S R Heller,et al. An interactive, versatile, three-dimensional display, manipulation and plotting system for biomedical research. , 1972, Journal of chemical documentation.